OSCP1

Across TCGA pan-cancer cohorts, OSCP1 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated OSCP1 data layer compared with 22 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher OSCP1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated OSCP1 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and PDAC show a favorable association.

CCRCC, LUAD, and UCEC are the cancer types where OSCP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Median	All	0.981	0.858	.002	36	view →
LUAD	OS	Quartile	III,IV	0.216	0.819	.008	20	view →
UCEC	OS	Median	II,III,IV	0.647	1.000	.017	18	view →
HNSC	DFS	Median	IV	0.523	0.806	.017	6	view →
PDAC	OS	Median	IV	0.836	0.491	.024	3	view →
LSCC	DFS	Quartile	II,III,IV	0.840	1.000	.034	2	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

OSCP1–CCRCC (DFS)

Open the CCRCC breakdown →